A Columbia University for Writing alum, Brad Tuttle in his article, 21 Incredibly Disturbing Facts About High Prescription Drug Prices published on Time.com addresses the topic of high drug prices and implies that drugs are very overpriced. He supports this claim by stating that, “The price of the life-saving drug Daraprim was jacked up 5,000% overnight last fall by the company that purchased it, Turing Pharmaceuticals, and its hated CEO Martin Shkreli” (Tuttle), then that the prices of “Epi Pens have increased 450% since 2007” (Tuttle). Tuttle’s purpose is to urge the drug companies to lower prices to life-saving drugs in order to make cancer and other diseases more affordable. He adopts a judgmental tone for his audience, the readers of Time
Unit 8 Assignment: Understanding Medicare Part D Tierra J. Neal Kaplan University Professor Eboni Green Health Policy May 2, 2016 Unit 8 Assignment: Understanding Medicare Part D In this paper I will provide information on the influences that helped stakeholders decide on the final outcome of Medicare Part D legislation. I will also list the different strategies and tools that were utilized to be most effective during the decision making of passing the legislation.
Shocking numbers such as the 200,000 people that have died from opioid overdoses were only amplified when broken down further to show that 46,000 of those deaths happened in 2016. Then he glosses over the temporary solution that has been enacted in which federal and state governments are restricting access to opioids, only to condemn it. He states that “The new policies are choking off access to the medications for some of the 87.5 million chronic-pain patients who take them according to their prescriptions and don't misuse them,” and then quickly relates it back to Deluca’s story, drawing out the reader’s
In 2013, California physician Daniel J. Stone wrote an article for the Los Angeles Times titled “Our Big Appetite for Healthcare.” Stone wrote this article because he wants people informed about the growing addiction that people in Southern California have for healthcare. He outlines how the problem is bad for both doctors and patients. By publishing this article, the Los Angeles Times hopes to have people more knowledgeable about the reality of overusing healthcare. Stone uses two persuasive strategies to interest readers.
Right now in the United States of America, there is a monopoly that exists that involves epinephrine auto-injectors. EpiPen is the United States only supplier of these auto-injectors because other brands have suffered setbacks and failures, patent protection laws, and because there are currently no generic versions of EpiPen in the United States (Johnson). This monopoly was not a problem until Mylan bought Meda AB in 2007 (Paton). “Since Mylan bought the rights to EpiPen in 2007, it has raised the price on 15 separate occasions, bringing the current list price to $608 for a two-pack up from about $50 a pen in 2007” (Mole). This has been a price increase of more than 500%, and this shows that Mylan has been using the monopoly to its advantage.
Nowadays it seems like legal drugs are more expensive than illegal ones. This dilemma occurs because the pharmaceutical industry affects the economy significantly. Although the United States is a mixed market economy, there are instances where the economy seems like a free market economy. A free market economy allows companies to determine the prices of goods free from government intervention. The pharmaceutical industry, despite several regulations set by the food and drug administration, is a free market economy.
Lori Chordas claims in her viewpoint that the production of generic versions of prescription drugs cuts the price of medication notably. Brand names can cost from thirty to eighty percent more than generic versions of the same medication. More Americans are recognizing the savings associated with buying generic brands instead of brand name. Generic drugs made up sixty five percent of prescription drugs distributed in 200 according to IMS Health.
II. Places of deaths, most effective prescription drug comparison between states. Prescription drug abuse became an issue in every state in the U.S., However, there are some states that have less number of deaths than others for not legalizing the types of drugs that the others states legalize, and abusers can be arrested for using non-medical drugs. Since the medical marijuana movement began, 23 states and the District of Columbia, starting with California in 1996, have legalized medical cannabis.
With regards to the idea of price regulating the EpiPen or not there are pros and cons to both sides. One could argue that the EpiPen should be regulated because one cannot choose to have a life-threatening allergy, resulting in epinephrine to be a drug that is required to live if something was to happen (Rashid, 2017). If one has a life-threatening allergy they would need epinephrine in case they were to go into anaphylactic shock. Due to the short-shelf life that epinephrine has, individuals who require epinephrine need to be able to purchase the EpiPen regularly (Rashid, 2017). If there is not a price regulation the price of the EpiPen can continue to increase which can cause those who need it to not be able to afford it (Rashid, 2017).
Better explained by Mom Junction “Prescription drugs are subsidised by insurance companies, which means customers are left with a small amount to pay, so buying them over the counter means you have to spend more. ”(Mankani, 2015) This affecting many of the American’s that pay for their
Without patient’s being aware of how to power the drug was, it eventually leads to the Opioids Crisis in America which now put a horrible word for the doctors and companies when it all starts by one person abusing the opioid pill. President Donald J. Trump idea that he had in mind was stated in the article of America’s Opioid Crisis, “But he reinforced the idea that the victims are to blame with an offhand reference to LSD.” Which indeed has the fact that people are to blame for misusage of the
Rebecca Watson, the speaker, made it clear her purpose was to inform you that while Martin Shkrelli had a huge role in the raising of Daraphim prices, he was not the only one to blame. She blames the entire pharmaceutical community for making it harder for people to access the medicine they need by constantly changing the prices. Watson builds upon her purpose by pulling out more opinions such as: “Homeopathy is bullshit and many chiropractors are dangerous quacks (Watson).” These opinions allows the reader to fully believe she is dislikes and puts blame on the pharmaceutical industry and the people within it. She specifically points out chiropractors which indicates there might have been an issue with one previously that allowed her to draw this conclusion.
When looking at a scholarly journal or other form of report pertaining to controlled substances, the theme is usually pretty clear; “drugs are bad, people that do drugs are bad, and it’s only getting worse.” Moore challenges this theme by breaking the mold in his article, “The Other Opioid Crisis” by implementing several rhetorical devices to add a more human aspect to the not so black-and-white issue. “The Other Opioid Crisis” is an article that goes into the ethics and the arguments regarding those who are in need of opioids and their stories, alongside other ethical issues they may face. By providing stories of patients, Moore states his opinion which is backed strongly by the pains, both mentally and physically, that opioid prescribed patients face. In these stories he not only provides a detailed account of their struggles, he uses strong language to appeal to the pathos of the reader on a subject that may not be easy for many to sympathize with.
Throughout the article Hightower utilizes specific diction that is casual yet makes his audience feel ashamed for being ignorant about prescription medicine issues that he presents. Therefore, when Hightower states, “‘We’ve identified 7,000 Americans who matter,’ this dismissing the other 330 million of us as nobodies,” many readers would become infuriated with the PhRMA because most people like to be relevant and considered. Also, when he says, “Moreover, they know they couldn’t possibly persuade us to let them keep jacking up our prices,” it makes his readers feel dumb if PhRMA was successful in persuading them or makes them feel prideful if they refuted PhRMA’s ridiculously high prices. Thus, Hightower is exceptional at persuading his audience to obtain a
Every citizen in the United States has individual rights protected by the Constitution. This protection also includes businesses that have gone through the legal process to become a legal entity ; more commonly known as becoming a corporation. Many times these individual rights, protected by the Constitution, conflict with the common good and as history shows, the courts consistently side with the common good when faced with a case that pits these two against each other. Big Pharma are corporations exercising their individual rights to market, and sell their product to consumers. In the process, the common good is suffering.
Porter’s five force model. Threat of New entrants (low): Although Walgreens and CVS are the giants in the retail pharmacy industry, there is a plenty of chances to small competitors. Entry into the brick-and-mortar prescription drug business is feasible even on a small scale.